Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Nenci GG and Paliani U | [Diabetes, coagulation and vascular events]. | 2000 | Recenti Prog Med | pmid:10748654 |
Bailey SR et al. | Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. | 2000 | Res. Vet. Sci. | pmid:10756136 |
Liao CH et al. | Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. | 2000 | J. Pharm. Pharmacol. | pmid:10757426 |
Prieto MA et al. | Influence of triflusal on platelet activation after coronary artery bypass graft. | 2000 | Blood Coagul. Fibrinolysis | pmid:10759013 |
Heller A et al. | The complement regulators C1 inhibitor and soluble complement receptor 1 attenuate acute lung injury in rabbits. | 2000 | Shock | pmid:10774617 |
Agnoli GC et al. | Renal synthesis of prostacyclin and thromboxane in healthy women: differential effects of a short-term saline loading. | 2000 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:10780876 |
Jacobs C et al. | 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromatase. | 2000 | J. Med. Chem. | pmid:10794700 |
Zhao S et al. | Glioma prostaglandin levels correlate with brain edema. | 1998 | J. Tongji Med. Univ. | pmid:10806839 |
Wakitani K et al. | JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues. | 2000 | Inflamm. Res. | pmid:10807499 |
Gardan B et al. | Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins. | 2000 | J. Cardiovasc. Pharmacol. | pmid:10813374 |